You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

consolidation post stem cell transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloma Trial in Philadelphia (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jun 13, 2022

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

Not yet recruiting
  • Acute Leukemia
  • Rifaximin with allogeneic stem cell transplant
  • Allogeneic stem cell transplant
  • (no location specified)
Sep 21, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

Recruiting
  • B Cell Lymphoma
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Plasma Cell Myeloma Trial in Buffalo (Belantamab Mafodotin, Lenalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 5, 2022

T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)

Withdrawn
  • T Cell Lymphoma
  • Brentuximab Vedotin
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Feb 1, 2023

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

Not yet recruiting
  • GATA2
  • Immunodeficiency
  • Mycophenolate Mofetil
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023